Episode 67
Biotech Hangout
00:00
The Importance of Partnership With Big Pharma Companies
We've always been and we still are jointly agnostic to the therapeutic areas in which we work. I think that's important because a lot of our opportunity comes from seismic shifts at other companies. Most of the transactions that we've done to build this portfolio have been built on clinical data. You win these deals by being in the right place at the right time That's really the only answer.
Transcript
Play full episode
